NCT04487847CompletedPhase 1/2
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
18F-PSMA-1007 PET to Detect Primary Prostate Cancer: a Comparative Study With mpMRI and Correlation to Histopathology
Source: ClinicalTrials.gov · Last updated 16 Jan 2025
Brief summary (registry, in English)
To study the added value of 18F-PSMA-1007 PET to mpMRI in the detection of local prostate cancer lesions.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- First submitted
- 22 Jul 2020
- Start date
- 1 Sept 2020
- Primary completion date
- 28 Feb 2023
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Prostate cancer
- NCT number
- NCT04487847
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 75
- From 1 Sept 2020 to the primary completion date, 28 Feb 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any prior surgery in the pelvic area that might interfere with the scans (e.g. hip replacement surgery)
Other illness
- History of prostate cancer
- Second active malignancy
- Any medical condition that in the opinion of the investigator will affect patients' clinical status when participating in this trial.
Other
- Prostate biopsy in the last 6 months
- Contra-indications for mpMRI or PET: claustrophobia or inability to lay still for the duration of the exam.
Who the study is looking for
- Suspicion for PCa (e.g. elevated PSA, suspicious rectal examination)
- Males ≥ 18 years
- ECOG 0-1
- Signed informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboud University Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.